Home Everest Medicines Enters Agreement with Corxel Pharmaceuticals for Greater China Development and Commercialization of LNZ100

Everest Medicines Enters Agreement with Corxel Pharmaceuticals for Greater China Development and Commercialization of LNZ100

Jun 08, 2026 07:02 CST Updated 09:25
Everest Medicines

Developer of Innovative Therapies

Corxel Pharmaceuticals Hong Kong

Cardiovascular Metabolic Disease Treatment Drug Developer